Oxford strengthens strategic partnerships with Vietnam in health, education and climate innovation
31 October 2025
The University of Oxford has signed three landmark agreements with leading Vietnamese partners, deepening collaboration across healthcare, higher education and sustainable aviation. The Tam Anh Research Institute has signed a Memorandum of Understanding with the International Health and Tropical Medicine Group from NDM Centre for Global Health Research, establishing the Tam Anh Oxford Partnership (TOP).
Ensitrelvir shows strong antiviral activity against COVID-19 in first head-to-head comparison with Paxlovid
28 October 2025
The oral antiviral ensitrelvir is a highly effective treatment for COVID-19, showing potent in-vivo antiviral activity comparable to ritonavir-boosted nirmatrelvir (Paxlovid), say MORU, Mahidol and University of Oxford researchers in a major international study published in The Lancet Infectious Diseases.
Innovative Oxford child anxiety treatment to be rolled out internationally
21 October 2025
An effective online treatment for childhood anxiety developed by a team at the University of Oxford is to be adapted and tested in five countries in Asia and South America, with the aim of driving widespread implementation in the future.
Anne Makena, Africa Oxford Initiative Co-Director steps down
15 October 2025
Dr Anne Makena, has announced her decision to transition from the role of Co-Director of the Africa Oxford initiative. A founding member of the Africa Oxford Initiative, Dr Makena has overseen the establishment and rapid growth of AfOx from conceptualisation to scaling for almost a decade.
Caesar Atuire awarded full professorship
14 October 2025
Philosopher and Health Ethicist Caear Atuire has been awarded the title of Professor, in recognition of his research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
FD-TACT malaria treatment trial launches patient recruitment in Rwanda
8 October 2025
A Phase 3 pivotal trial, led by MORU and funded by Japan’s Global Health Innovative Technology Fund (GHIT), has begun to evaluate a novel fixed-dose triple artemisinin-based combination treatment (FD-TACT) for uncomplicated Plasmodium falciparum malaria.
Kevin Marsh awarded RSTMH’s 2025 Sir Patrick Manson Medal
1 October 2025
The Royal Society of Tropical Medicine and Hygiene's most prestigious award, the Sir Patrick Manson Medal, is being given this year to Professor Kevin Marsh, a Malariologist and Global Health Researcher. Professor Marsh is the Director of the Africa Oxford Initiative and Senior Adviser Science for Africa Foundation at the University of Oxford. His major research interests focus on immunity to and pathogenesis of malaria, and he has a particular interest in supporting science and scientific leadership across Africa.
New study find treatment for Chagas disease is excessive
23 September 2025
A new study has found the current recommended treatment for Chagas disease could be given over a substantially shorter time period and still be as effective.
Tracking resistance: Mapping the spread of drug-resistant malaria
20 August 2025
On World Mosquito Day, Dr Lucy Harrison, postdoctoral researcher at Oxford’s Infectious Diseases Data Observatory (IDDO) at the Centre for Tropical Medicine and Global Health, reflects on the global impact of the mosquito and her research into malaria drug resistance.
Severe nurse shortages in Kenya undermine newborn care, despite advancements
14 August 2025
A multi-disciplinary study by KEMRI-Wellcome Trust, Harnessing Innovation in Global Health for Quality Care (HIGH-Q), has revealed how workforce issues influence the quality of care in newborn units. The research highlighted the effect of severe nurse staffing shortages in Kenyan hospitals as a major obstacle to providing quality care for newborns.
Simple new method that measures viral clearance means antibody treatments for COVID and ‘flu can be quickly assessed for effectiveness, say MORU researchers
7 August 2025
Measuring the rate of viral clearance from the back of the mouth in patients with mild infections can be used to determine quickly and inexpensively if an antibody is effective in future COVID-19, influenza and other respiratory virus pandemics, say researchers in a letter published today in The Lancet.
Global Action Needed to Tackle Noma Disease
5 August 2025
Greater surveillance and well-designed epidemiological studies for noma should be a research priority. A new BMJ Global Health paper reveals major gaps in research on noma, a severe and often fatal oral disease affecting children in low-resource settings. Despite WHO recognition of noma as a neglected tropical disease, limited data exists on its causes, burden, and treatment. The study calls for standardised reporting, increased surveillance, and improved early detection. Conducted by IDDO and WHO, the review analysed 366 studies to provide a comprehensive foundation for future research and policy action.
From Despair to Collective Action: Reflections from the Global Health Solidarity Open Forum 2025
22 July 2025
The Global Health Solidarity Open Forum 2025 convened over 150 global participants to explore solidarity in research and practice. Speakers emphasised power redistribution, equitable partnerships, and community-led engagement in global health. Discussions highlighted the importance of shifting from aid to collaboration, ensuring solidarity becomes a driving force in shaping just, resilient health systems.
Real-time genetic surveillance can support timely, evidence-based responses to shifting malaria threats
25 June 2025
A sharp decline in piperaquine-resistant strains of P. Falciparum malaria following drug policy revisions across the Greater Mekong Subregion (GMS) highlights how real-time genetic data can support timely, evidence-based responses to shifting malaria threats, say researchers in a study published in Nature Communications.
Oxford academics awarded European Research Council Advanced Grants for cutting-edge research
17 June 2025
Professor Deirdre Hollingsworth and six researchers at the University of Oxford have been awarded Advanced Grants from the European Research Council, each worth up to €2.5 million over a period of five years.
Interview with Trudie Lang, mpox surging in Sierra Leone
13 June 2025
As mpox cases rise in Sierra Leone, Professor Trudie Lang helps us understand the implications of the continuing spread of the disease, why it matters and how global efforts to tackle the outbreak are progressing.
Nipah virus vaccine granted European Medicines Agency PRIME designation
11 June 2025
Co-led by researchers at the Pandemic Sciences Institute, the Nipah virus has been granted PRIME designation. This recognises the vaccine’s potential to address the unmet medical need arising from the devastating Nipah virus disease, which can be fatal in up to 85% of cases.
CTMGH LinkedIn takeover by MSc IHTM students starts 3 June
23 May 2025
Get ready! - the CTMGH LinkedIn takeover begins on Tuesday 3 June and eight students from our MSc in International Health and Tropical Medicine, who are currently working around the world, will be sharing their research placement experience.
Researchers awarded Associate Professorships
20 May 2025
We are delighted to announce that Abdirahman Abdi and Alice Norton have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
Engaging stakeholders to build a Kenyan learning health system success in Vice-Chancellor’s Awards
20 May 2025
Work led by a NDM Centre for Global Health Research (CGHR) and KEMRI-Wellcome team `Engaging stakeholders to build a Kenyan learning health system’ was recognised as winner of the Vice-Chancellor’s Research Engagement Award on Thursday 15 May where the team was represented by Professor Mike English.